[1] LI F, CUI J, SHI ZL. Origin and evolution of pathogenic coronaviruses[J]. Nat Rev Microbiol, 2019, 17(3):181-192
[2] LIU DX, FUNG ST. Human Coronavirus: Host-Pathogen Interaction[J]. Annu Rev Microbiol, 2019, 73:529-557
[3] MCGRATH ME, MILLER K, HU Z, et al. Coronavirus interactions with the cellular autophagy machinery[J]. Autophagy, 2020, 16(12): 2131-2139
[4] DEES JH, MCLNTOSH K, BECKER WB, et al. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease[J]. Proc Natl Acad Sci U S A, 1967, 57(4):933-40
[5] PROCKNOW JJ, HAMRE D. A new virus isolated from the human respiratory tract[J]. Proc Soc Exp Biol Med, 1966, 121(1):190-3
[6] DOREMALEN NV, WIT ED, FALZARANO D, et al. SARS and MERS: recent insights into emerging coronaviruses[J]. Nat Rev Microbiol, 2016, 14(8):523-34
[7] ZHENG BJ, ZHONG NS, LI YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003[J]. Lancet, 2003, 362:1353–1358
[8] FIELDING BC, CHAFEKAR A. MERS-CoV: Understanding the Latest Human Coronavirus Threat[J]. Viruses 2018, 10(2)
[9] ZHAO X, LU R, LI J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224):565-574
[10] HOLMES EC, ZHANG YZ. A genomic perspective on the origin and emergence of SARS-CoV-2[J]. Cell, 2020 181(2):223-227
[11] LEBLANC JJ, TALI SHA, SADIQ Z, et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection[J]. Clin Microbiol Rev, 2021, 34(3):e00228-20
[12] RAMELLI SC, STEIN SR, GRAZIOLI A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy[J]. Nature, 2022, 612(7941):758-763
[13] GARY J, BHATNAGAR J, STEINER SR, et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. [J]. J Infect Dis, 2021, 223(5):752-764
[14] NEYAZ A, DESAI N, SZABOLCS A, et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection[J]. Nat Commun, 2020, 11(1):6319
[15] MASTERS PS. The molecular biology of coronaviruses[J]. Adv VirusRes, 2006, 66:193-292
[16] MARTIN SN, WEISS SR. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus[J]. Microbiol Mol Biol Rev, 2005, 69(4):635-64
[17] Peter V. Markov, Mahan Ghafari, Martin Beer, et al. The evolution of SARS-CoV-2[J]. Nature Reviews Microbiology, 2023
[18] LIU Q, CHEN Y, GUO D. Emerging coronaviruses: genome structure, replication, and pathogenesis[J]. J Med Virol, 2020, 92, 418–423
[19] RAO Z, YANG H. Structural biology of SARS-CoV-2 and implications for therapeutic development[J]. Nat Rev Microbiol 2021, 19, 685–700
[20] HE Y, Du L, ZHOU Y, et al. The spike protein of SARS-CoV--a target for vaccine and therapeutic development[J]. Nat Rev Microbiol, 2009, 7(3): 226 - 236
[21] ROLLE ML, HSU JCC, PAWLAK JB, et al. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein[J]. Proc Natl Acad Sci U S A 2021, 118(24):e2101161118
[22] X. Lei, X. Dong, R. Ma, et al. Activation and evasion of type I interferon responses by SARS-CoV-2[J]. Nat Commun, 2020, 11(1): 3810.
[23] Z. Jin, X. Du, Y. Xu, et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors[J]. Nature, 2020, 582(7811): 289-293.
[24] S. Angeletti, D. Benvenuto, M. Bianchi, et al. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis[J]. J Med Virol, 2020, 92(6): 584 -588.
[25] aS. Ricciardi, A. M. Guarino, L. Giaquinto, et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle[J]. Nature, 2022,606(7915): 761-768;
[26] S. M. S. Reshamwala, V. Likhite, M. S. Degani, et al. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure[J]. J Med Virol, 2021, 93(7): 4616- 4619.
[27] aB. Wang, D. Svetlov, I. Artsimovitch. NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain[J]. Nucleic Acids Res, 2021, 49(15):8822-8835; bG. J. Park, A. Osinski, G. Hernandez, et al. The mechanism of RNA capping by SARS-CoV-2[J]. Nature, 2022, 609(7928): 793-800.
[28] H. T. Baddock, S. Brolih, Y. Yosaatmadja, et al. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification[J]. Nucleic Acids Res, 2022,50(3): 1484-1500.
[29] H. S. Hillen, G. Kokic, L. Farnung, et al. Structure of replicating SARSCoV-2 polymerase[J]. Nature, 2020, 584(7819): 154-156.
[30] J. A. Newman, A. Douangamath, S. Yadzani, et al. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase[J]. Nat Commun, 2021, 12(1): 4848.
[31] ORTIZ PS, BELKACEM RA, GUIRAUD M, et al. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase[J]. Eur J Med Chem, 2020, 201: 112557
[32] SCHAPIRA M, DEVKOTA K, PERVEEN S, et al. Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors[J]. SLAS Discov, 2021,26(9): 1200-1211
[33] C. K. Yuen, J. Y. Lam, W. M. Wong, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists[J]. Emerg Microbes Infect, 2020, 9(1): 1418-1428.
[34] A. K. Banerjee, M. R. Blanco, E. A. Bruce, et al. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses[J]. Cell, 2020, 183(5): 1325-1339.e1321.
[35] C. B. Jackson, M. Farzan, B. Chen, et al. Mechanisms of SARS-CoV-2 entry into cells[J]. Nat Rev Mol Cell Biol, 2022, 23(1): 3-20.
[36] XIAO Z, YANG Y, YE K, et al. . SARS-CoV-2: characteristics and current advances in research[J]. Virol J, 2020, 17(1): 117
[37] YANG H, RAO Z. Structural biology of SARS-CoV-2 and implications for therapeutic development[J]. Nat Rev Microbiol, 2021, 19, 685–700
[38] KRATZEL A, VKOVSKI P, STEINER S, et al. Coronavirus biology and replication: implications for SARS-CoV-2[J]. Nat Rev Microbiol, 2021 19(3):155-170
[39] FARZAN M, JACKSON CB, CHEN B, et al. Mechanisms of SARSCoV-2 entry into cells[J]. Nat Rev Mol Cell Biol, 2022, 23(1): 3–20
[40] ENJUANES L, GORBALENYA AE, ZIEBUHR J, et al. Nidovirales: evolving the largest RNA virus genome[J]. Virus Res, 2006, 117:17–37
[41] LMBERT I, SUBISSI L, FERRON F, et al. SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets[J]. AntiviralRes, 2014, 101:122-30
[42] KRATZEL A, VKOVSKI P, STEINER S, et al. Coronavirus biology and replication: implications for SARS-CoV-2[J]. Nat Rev Microbiol, 2021,19(3):155-170
[43] DECROLY E, SNIJDER EJ, ZIEBUHR J, et al. The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing[J]. Adv Virus Res,2016, 96: 59-126
[44] Plotkin S. History of vaccination[J]. Proc Natl Acad Sci U S A, 2014,111(34):12283-7
[45] SILVA MMG, BERNAL AJ, MUSUNGAIE DB, et al. . Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. [J]. N Engl J Med, 2022, 386(6):509-520
[46] CANARD B, SHANNON A. Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2[J]. Antiviral Res, 2023, 210:105501
[47] ALLERTON CMN, OWEN DR, ANDERSON AS, et al. An oral SARSCoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19[J]. Science, 2021, 374(6575):1586-1593
[48] MURAKAMI N. Therapeutic advances in COVID-19[J]. Nat Rev Nephrol 2023, 19, 38–52
[49] TAURIN S, BAKHIET M. SARS-CoV-2: Targeted managements and vaccine development[J]. Cytokine Growth Factor Rev, 2021, 58:16-29
[50] STAMATELOPOULOS K, TROUGAKOS LP, TERPOS E, et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications[J]. J Biomed Sci, 2021, 28(1):9
[51] BUSSEL JB, CINES DB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.[J]. N Engl J Med, 2021, 384(23):2254-2256
[52] PLOTKIN S. History of vaccination. [J]. Proc Natl Acad Sci U S A, 2014, 111(34):12283-7
[53] SATZ AL. DNA-encoded chemical libraries[J]. Nature, 2022, 3 (2022)
[54] DUMELIN CE, JR RAG, KEEFE AD. DNA-encoded chemistry: enabling the deeper sampling of chemical space[J]. Nat Rev Drug Discov, 2017,16(2):131-147
[55] PAEGEL BM, FITZGERALD PR. DNA-Encoded Chemistry: Drug Discovery from a Few Good Reactions[J]. Chem Rev, 2021, 121(12):7155-7177
[56] ACHARYA RA, CLARK MA, MUENDEL CCA, et al. Design, synthesis and selection of DNA-encoded small-molecule libraries[J]. Nat Chem Biol, 2009, 5(9):647-54
[57] HWANG GT, SONG M. DNA-encoded library screening as core platform technology in drug discovery: its synthetic method development and applications in DEL synthesis.[J]. J Med Chem 2020, 63(13):6578-6599
[58] GOTTE K. Reaction development for DNA-encoded library technology: from evolution to revolution? [J]. Tetrahedron Lett, 2020, 61, 151889
[59] PLOWRIGHT AT, DAVIS AM, VALEUR E Directing evolution: the next revolution in drug discovery?[J]. Nat Rev Drug Discov, 2017, 16(10):681 - 698
[60] ZHANG Y, MANNOCCI L, SCHEUERMANN J, et al. High-throughput sequencing allows the identification of binding molecules isolated from DNAencoded chemical libraries[J]. Proc Natl Acad Sci U S A, 2008, 105(46):17670 -5
[61] OSINSKI A, PARK GJ, HERNANDEZ G, et al. The mechanism of RNA capping by SARS-CoV-2[J]. Nature, 2022, 609(7928):793-800
[62] LIN CH, PENG YH, LIN CN, et al. Characterization of the Role of Hexamer AGUAAA and Poly(A) Tail in Coronavirus Polyadenylation[J]. PLoS ONE, 2016 11(10):e0165077
[63] L. Yan, Y. Yang, M. Li, et al. Coupling of N7-methyltransferase and 3'- 5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading[J]. Cell, 2021, 184(13): 3474-3485.e3411.
[64] S. Zhang, J. Wang, L. Wang, et al. SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1[J]. Cell Mol Immunol, 2022,19(8): 872-882.
[65] TAHIR M. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target[J]. J Med Virol, 2021,93(7):4258-4264
[66] ZHU XX, LIU C, LU Y, et al. Potential treatment with Chinese and Western medicine targeting NSP14 of SARS-CoV-2[J]. J Pharm Anal, 2021, 11(3):272-277.
[67] HILLEN HS, KOKIC G, TEGUNOV D, et al. Mechanism of SARSCoV-2 polymerase stalling by remdesivir[J]. Nat Commun, 2021, 12(1):279
[68] STEVENS LJ GRIBBLE J, AGOSTINI ML, et al. The coronavirus proofreading exoribonuclease mediates extensive viral recombination[J]. PLoS Pathog, 2021, 17(1):e1009226
[69] WU L, MA Y, SHAW N, et al. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex[J]. Proc Natl Acad Sci U S A, 2015, 112(30):9436-41
[70] DOLY J, BIRNBOIM HC. A rapid alkaline extraction procedure for screening recombinant plasmid DNA[J]. Nucleic Acids Res, 1979, 7(6):1513-23
[71] Joshua Lederberg. Cell Genetics and Hereditary Symbiosis[J]. Physiological Reviews, 1952, 32(4): 403-430.
[72] EL Wollman, F Jacob. The Process of Conjugation and Recombination in E. coli. V. The Mechanism of Transfer of Genetic Material[J]. Ann Inst Pasteur, 1958, 95(6): 641-666.
[73] BOULBEN S, CHASSE H, COSTACHE V, et al. Analysis of translation using polysome profiling [J]. Nucleic Acids Res, 2017, 45(3):e15
[74] SASSE J, GALLAGHER S. Protein analysis by SDS-PAGE and detection by Coomassie blue or silver staining[J]. Curr Protoc Pharmacol, 2001, Appendix 3:3B
[75] CAMPOY AV. Isothermal titration calorimetry[J]. Curr Protoc Cell Biol, 2004, Chapter 17:Unit 17.8
[76] AUCLAIR K FREIBURGER L, MITTERMAIER A. Elucidating protein binding mechanisms by variable-c ITC[J]. ChemBioChem, 2009, 10(18):2871-3
[77] WARD WHJ, HOLDGATE GA. Measurements of binding thermodynamics in drug discovery[J]. Drug Discovery Today, 2005,10(22):1543-50
[78] FRANKLINN GC, BUIJS J. SPR-MS in functional proteomics[J]. Brief Funct Genomic Proteomic, 2005, 4:39–47
[79] AUCLAIR K, FREIBURGER L, MITTERMAIER A. Global ITC fitting methods in studies of protein allostery[J]. Methods, 2015 76:149-161
[80] JOHNSON CM. Isothermal titration calorimetry[J]. Methods Mol Biol, 2021, 2263:135-159
[81] ANUSIEM AC, EFTINK MR, BILTONEN RL. Enthalpy-entropy compensation and heat capacity changes for protein-ligand interactions: general thermodynamic models and data for the binding of nucleotides to ribonuclease A[J]. Biochemistry, 1983 22(16):3884-96
[82] PARK J, NGUYEN HH, KANG S, et al. Surface Plasmon Resonance: A Versatile Technique for Biosensor Applications[J]. Sensors (Basel), 2015 15(5):10481–10510
修改评论